Therapeutic compounds
    2.
    发明授权
    Therapeutic compounds 有权
    治疗化合物

    公开(公告)号:US08518928B2

    公开(公告)日:2013-08-27

    申请号:US13308197

    申请日:2011-11-30

    IPC分类号: A61K31/35 C07D245/00

    CPC分类号: C07D498/22

    摘要: The invention provides compounds of formula I: wherein A, B, D, E, R1, R2, R3, R4, R5, X, and - - - have any values defined herein, as well as salts thereof. The compounds have activity as G-quadruplex DNA stabilizers and as anti-proliferative agents.

    摘要翻译: 本发明提供式I化合物:其中A,B,D,E,R 1,R 2,R 3,R 4,R 5,X和 - 具有本文定义的任何值及其盐。 该化合物具有作为G-四链体DNA稳定剂和抗增殖剂的活性。

    TOPOISOMERASE INHIBITORS
    6.
    发明申请
    TOPOISOMERASE INHIBITORS 有权
    TOPOISOMERASE抑制剂

    公开(公告)号:US20120237531A1

    公开(公告)日:2012-09-20

    申请号:US13318455

    申请日:2010-11-04

    摘要: The invention provides compounds of formula I: (I) wherein A, B, W, Y, Z, R1, R3 and R4 have any of the meanings defined in the specification and their salts as well as additional compounds and their salts. The invention also provides pharmaceutical compositions comprising a compound of the invention, processes for preparing compounds of the invention, intermediates useful for preparing compounds of the invention, and therapeutic methods for treating cancer, a bacterial infection or a fungal infection using compounds of the invention.

    摘要翻译: 本发明提供式I化合物:(I)其中A,B,W,Y,Z,R 1,R 3和R 4具有本说明书中定义的任何含义及其盐以及其它化合物及其盐。 本发明还提供包含本发明化合物的药物组合物,用于制备本发明化合物的方法,用于制备本发明化合物的中间体,以及使用本发明化合物治疗癌症,细菌感染或真菌感染的治疗方法。

    TOPOISOMERASE-TARGETING AGENTS
    9.
    发明申请
    TOPOISOMERASE-TARGETING AGENTS 有权
    TOPOISOMERASE定向试剂

    公开(公告)号:US20090258890A1

    公开(公告)日:2009-10-15

    申请号:US12422394

    申请日:2009-04-13

    CPC分类号: C07D491/04

    摘要: The invention provides compounds of formula I or formula II: wherein: the bond represented by is a single bond or a double bond, and R1-R5, X, and Y have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I or II, processes for preparing compounds of formula I or II, intermediates useful for preparing compounds of formula I or II, and therapeutic methods for treating cancer and other topoisomerase related conditions using compounds of formula I or II.

    摘要翻译: 本发明提供式I或式II化合物:其中:由是单键或双键,R1-R5,X和Y具有说明书及其药学上可接受的盐中定义的任何含义。 本发明还提供了包含式I或II化合物的药物组合物,制备式I或II化合物的方法,可用于制备式I或II化合物的中间体,以及用于治疗癌症和其它拓扑异构酶相关病症的治疗方法, 公式I或II。